394 related articles for article (PubMed ID: 3108356)
1. The GH-releasing hormone (GHRH) test in acromegaly before and after adenomectomy.
Giusti M; Lomeo A; Monachesi M; Mazzocchi G; Attanasio R; Sessarego P; Mignone D; Del Monte P; Giordano G
J Endocrinol Invest; 1987 Apr; 10(2):143-51. PubMed ID: 3108356
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone (GH) and prolactin responses to repetitive administration of GH-releasing hormone in acromegaly.
Losa M; Schopohl J; König A; Müller OA; von Werder K
J Clin Endocrinol Metab; 1986 Aug; 63(2):475-80. PubMed ID: 3088026
[TBL] [Abstract][Full Text] [Related]
3. Effect of acute pharmacological modulation of plasma free fatty acids on GH secretion in acromegalic patients.
Cordido F; Peñalva A; Martinez T; Casanueva FF; Dieguez C
Clin Endocrinol (Oxf); 2001 Apr; 54(4):509-13. PubMed ID: 11318787
[TBL] [Abstract][Full Text] [Related]
4. Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly.
Shibasaki T; Hotta M; Masuda A; Imaki T; Obara N; Hizuka N; Takano K; Wakabayashi I; Demura H; Ling N
J Clin Endocrinol Metab; 1986 Jul; 63(1):167-73. PubMed ID: 2872226
[TBL] [Abstract][Full Text] [Related]
5. The higher the growth hormone response to growth hormone releasing hormone the lower the response to bromocriptine and thyrotrophin releasing hormone in acromegaly.
Smals AE; Pieters GF; Smals AG; Hermus AR; Benraad TJ; Kloppenborg PW
Clin Endocrinol (Oxf); 1987 Jul; 27(1):43-7. PubMed ID: 3115634
[TBL] [Abstract][Full Text] [Related]
6. Relationship between somatomedin-C and growth hormone levels in acromegaly: basal and dynamic evaluation.
Oppizzi G; Petroncini MM; Dallabonzana D; Cozzi R; Verde G; Chiodini PG; Liuzzi A
J Clin Endocrinol Metab; 1986 Dec; 63(6):1348-53. PubMed ID: 2878007
[TBL] [Abstract][Full Text] [Related]
7. Pulsatile growth hormone secretion in patients with acromegaly and normal men: the effects of growth hormone-releasing hormone infusion.
Gelato MC; Oldfield E; Loriaux DL; Merriam GR
J Clin Endocrinol Metab; 1990 Sep; 71(3):585-90. PubMed ID: 2118536
[TBL] [Abstract][Full Text] [Related]
8. Human pancreatic growth hormone-releasing factor (hpGRF-44) in acromegaly before and after adenomectomy. Modifications induced by somatostatin (GHRIH) infusion.
Arosio M; Ambrosi B; Guglielmino L; Faglia G
J Endocrinol Invest; 1985 Oct; 8(5):449-53. PubMed ID: 2867112
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide modulates in vivo and in vitro growth hormone release in acromegaly.
Cuttica CM; Giusti M; Bocca L; Sessarego P; De Martini D; Valenti S; Spaziante R; Giordano G
Neuroendocrinology; 1997 Dec; 66(6):426-31. PubMed ID: 9430448
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone releasing hormone-sensitive adenylate cyclase activity in growth hormone-producing pituitary adenoma: correlation to the response of plasma growth hormone to growth hormone releasing hormone in patients with acromegaly.
Natori S; Ikuyama S; Haji M; Ohashi M; Nawata H
Endocrinol Jpn; 1989 Apr; 36(2):229-36. PubMed ID: 2550207
[TBL] [Abstract][Full Text] [Related]
11. Lack of desensitization of adenomatous somatotrophs to growth-hormone releasing hormone in acromegaly.
Spada A; Elahi FR; Arosio M; Sartorio A; Guglielmino L; Vallar L; Faglia G
J Clin Endocrinol Metab; 1987 Mar; 64(3):585-91. PubMed ID: 3102543
[TBL] [Abstract][Full Text] [Related]
12. Cholinergic involvement in the growth hormone releasing hormone-induced growth hormone release: studies in normal and acromegalic subjects.
Massara F; Ghigo E; Demislis K; Tangolo D; Mazza E; Locatelli V; Müller EE; Molinatti GM; Camanni F
Neuroendocrinology; 1986; 43(6):670-5. PubMed ID: 3093909
[TBL] [Abstract][Full Text] [Related]
13. Effects of theophylline infusion on the growth hormone (GH) and prolactin response to GH-releasing hormone administration in acromegaly.
Losa M; Alba-Lopez J; Schopohl J; Sobiesczcyk S; Chiodini PG; Müller OA; von Werder K
J Endocrinol Invest; 1988 Oct; 11(9):663-7. PubMed ID: 3146595
[TBL] [Abstract][Full Text] [Related]
14. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
Ishibashi M; Yamaji T
J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of selective transsphenoidal adenomectomy by endocrinological testing and somatomedin-C measurement in acromegaly.
Losa M; Oeckler R; Schopohl J; Müller OA; Alba-Lopez J; von Werder K
J Neurosurg; 1989 Apr; 70(4):561-7. PubMed ID: 2647918
[TBL] [Abstract][Full Text] [Related]
16. Bromocriptine does not alter growth hormone (GH) responsiveness to GH-releasing hormone in acromegaly.
Cozzi R; Dallabonzana D; Oppizzi G; Verde G; Liuzzi A; Chiodini PG
J Clin Endocrinol Metab; 1986 Mar; 62(3):601-4. PubMed ID: 3080469
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of the growth hormone response to vasoactive intestinal peptide and gonadotropin-releasing hormone in acromegaly.
Watanobe H; Tamura T
Neuropeptides; 1995 Feb; 28(2):115-24. PubMed ID: 7746355
[TBL] [Abstract][Full Text] [Related]
18. Persistence of rapid growth hormone (GH) pulsatility after successful removal of GH-producing pituitary tumors.
Ho PJ; Jaffe CA; Friberg RD; Chandler WF; Barkan AL
J Clin Endocrinol Metab; 1994 Jun; 78(6):1403-10. PubMed ID: 7911124
[TBL] [Abstract][Full Text] [Related]
19. Effects of sumatriptan on growth hormone releasing hormone-stimulated growth hormone secretion in acromegaly.
Cuttica CM; Sessarego P; Ponzani P; Falivene MR; Valenti S; De Martini D; Giusti M
Recenti Prog Med; 1997 Jun; 88(6):264-8. PubMed ID: 9233053
[TBL] [Abstract][Full Text] [Related]
20. A re-evaluation of the prolactin-releasing activity of growth hormone-releasing hormone in acromegaly in vivo.
Watanobe H; Tamura T
Neuropeptides; 1995 Feb; 28(2):73-8. PubMed ID: 7746357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
